Shortening Buruli Ulcer treatment: WHO recommended vs. a novel beta-lactam-containing therapy - Phase III evaluation in West Africa
Acronym:
BLMs4BU
Principal researcher:
Santiago Ramón García
Managing entity:
OPE - Universidad de Zaragoza
Scope:
Nacional
Entidades participantes:
Universidad de Zaragoza
Fondation Raoul Follereau
Instituto de Salud Carlos III
DAHW Deutsche Lepra-und Tuberkulosehilfe e. V.,
Kwame Nkrumah University of Science and Technology
Ghana Health Service
Programme National de Lutte Contre l'Ulcère de Buruli, Côte d'Ivoire
Programme National des Maladies Tropicales Negligées, Togo
Fundación ARAID
Number of researchers:
50
Start date:
12/2021
End date:
11/2025